Three biotech companies, Actio Biosciences, AIRNA Therapeutics, and Alesta Therapeutics, have recently raised significant funding to advance treatments for genetic diseases. Actio Biosciences is developing treatments for rare neurological conditions, while AIRNA Therapeutics is working on a “RNA cure” for alpha-1 antitrypsin deficiency. Alesta Therapeutics is focusing on orally available small-molecule therapies for genetic disorders….
Biotech on The Soothsayer
Labiotech has released a retrospective analysis of their 2024 biotech companies to watch list, highlighting the progress and successes of the selected companies. The analysis reveals that some companies have exceeded expectations, while others have made steady progress. The article provides an update on the current status of the companies and assesses their potential for…
Belgium’s biotech sector is thriving, with over 300 biopharmaceutical companies operating in the country. Eight companies, including AgomAb Therapeutics and Augustine Therapeutics, are making significant strides in the clinic, with promising treatments for fibrotic diseases and nerve disorders. These companies are poised to make a significant impact in the biotech industry in the coming years….
A list of the best biotech books has been curated, covering topics from science fiction thrillers to eye-opening discoveries. The books explore the world of biotechnology, including immunosuppressant drugs, the microbiome, and de-extinction. These stories highlight the potential and risks of biotech advancements, from solving human challenges to manipulating life. Forecast for 6 months: Increased…
The BIO International Convention 2025 in Boston highlighted the region’s leading role in the global biotech landscape. Several influential biotech companies, including Moderna and Vertex Pharmaceuticals, are headquartered in Boston. This article takes a closer look at 14 biotech companies shaping the future from this powerhouse hub, including Akouos, Alterome Therapeutics, and Ascidian Therapeutics. Forecast…
Wales is witnessing a significant growth in its biotech sector, driven by initiatives from the Welsh government and support from science parks, med-tech companies, and universities. The industry has generated a £2.62 billion turnover in 2022 and is expected to continue its upward trend. Biotech startups like Jellagen are making waves with innovative products, and…
The demand for sustainable food solutions has led to a surge in lab-grown meat companies, with Aleph Farms, Believer Meats, and BioBetter at the forefront of this revolution. These companies are using cell-based technology to produce meat without harming animals or the environment, making it possible for future generations to enjoy meat without the guilt….
Biotech companies Judo Bio and Maze Therapeutics are making significant strides in developing innovative treatments for kidney disease. Judo Bio’s oligonucleotide therapies, delivered to the kidney via its STRIKE platform, have shown promising results in preclinical studies. Meanwhile, Maze Therapeutics’ APOL1 inhibitor, MZE829, has completed phase 1 trials and is now in phase 2 testing….
France’s biotech sector is experiencing a surge in innovation, driven by a growing number of startups and government initiatives. Companies like Bioptimus, Brenus Pharma, and Brink Therapeutics are developing cutting-edge technologies, including AI-driven diagnostics, regenerative therapies, and programmable recombinases. The France 2030 plan is helping to bridge the funding gap, ensuring that promising innovations have…
The biotech industry is witnessing significant advancements in interleukin therapeutics, a group of signaling proteins that play a crucial role in modulating immune responses. Companies like Ankyra Therapeutics and Asher Bio are developing innovative treatments that harness the power of interleukins to enhance local immune activation while minimizing systemic exposure and associated toxicities. These breakthroughs…